Early notification – Cefuroxime
New listing in Section H (HML) from 1 December 2017.
Cefuroxime Actavis Inj 750 mg & 1.5 g vials 10 pack.
Incumbent Zinacef Inj 750 mg & 1.5 g will be delisted from HML 1 February 2018.
Further information is provided on our website under Pharmac Changes.
As of the date of this notification ProPharma / PWR cannot accept Zinacef for credit under any circumstances.